Pre-Market Overview: November 24, 2025

Prepared for Decision-Makers | Compliance ID: MO-2025-1124-PM | Not Investment Advice

---

U.S. pre-market futures are higher on Monday (Nov 24) as rate-cut hopes and Treasury Secretary Scott Bessent’s recession reassurance (no 2026 recession) lift sentiment ahead of a shortened Thanksgiving week [1][2][3]. Healthcare and industrials sectors lead pre-market gains, while tech-focused Nasdaq futures outpace broader indices amid signs of recovery from November’s AI-driven pullback [0][2]. Mixed housing data (rising existing sales but falling multifamily starts) underscores Bessent’s note of challenged rate-sensitive sectors [5][6].

---

• Nasdaq 100
  : +0.99% (as of 3:39 AM EST) [2]
• S&P 500
  : +0.68% [2]
• Dow Jones
  : +0.36% [2]
• Commodities
  : Gold ($4,066, -0.1%), WTI Oil ($57.94, -0.21%) [3]

Top Gainers:

• Healthcare (+1.73%) [0]
• Industrials (+1.52%) [0]
• Basic Materials (+1.39%) [0]

Laggards:

• Utilities (-0.89%) [0]
• Technology (+0.15%) [0] (modest recovery after 6% November decline) [4]

• Existing home sales: +1.2% (median price: $415,200, +2.1% YoY) [6]
• Multifamily starts: -38.5% (offsetting single-family gains of +2.2%) [5]
• Builder confidence: HMI rose to
  37
  (highest since April) [7]

---

1. Bessent’s Recession Reassurance
   :
   Treasury Secretary Scott Bessent stated the U.S. will avoid a 2026 recession, citing:
   • Permanent extension of Trump’s 2017 tax cuts [1]
   • Upcoming healthcare cost relief measures (to be announced this week) [1]
   • Weakness in housing and rate-sensitive sectors (acknowledged) [1]

2. Rate-Cut Hopes
   :
   New York Fed President John Williams hinted at a
   December rate cut possibility
   , with markets pricing a
   60% chance
   of a cut [2][4].

3. Shortened Trading Week
   :
   • Markets closed Thursday (Thanksgiving)
   • Early close Friday (1 PM ET) [4]

4. Bayer’s Drug Trial Success
   :
   Bayer’s secondary stroke drug met late-stage trial goals, lifting its stock pre-market [8].

5. Government Shutdown Impact
   :
   Q4 economic data may show weakness due to the
   43-day shutdown
   (longest in U.S. history) [1][4].

---

1. Bayer
   : Up pre-market on stroke drug trial success [8]
2. Alibaba
   : +3% pre-market after Qwen AI hit
   10 million downloads
   [2]
3. TCS
   : U.S. court upheld a
   $194 million penalty
   (trade secrets case vs. DXC) but vacated an injunction restricting software use [10]
4. Prosus/Naspers
   : Reported 1H results, on track for FY adjusted EBITDA guidance [9]

---

• Thanksgiving closure (Nov 27) and early Friday close [4]

1. Fed’s December Policy Meeting
   : Market expects rate cut clarity [2]
2. Healthcare Cost Relief
   : Trump admin to announce measures this week [1]
3. Economic Data
   : November existing home sales (Dec 19 release) [6]

• Shortened week volatility
• AI sector valuation concerns (Nasdaq down
  6%
  in November) [2][4]
• Mixed housing sector trends [5][6]

---

[0] Ginlix Analytical Database (Sector Performance)
[1] CNBC: Bessent believes there won’t be a recession in 2026 but says some sectors are challenged
[2] Economic Times: US stock futures today: AI sell-off eases as Dow, S&P500 and Nasdaq rebound into Thanksgiving week
[3] Markets Insider: Premarket | Futures | Pre-market Trading
[4] CNBC: Stock market today: Live updates
[5] Construction Dive: Construction starts surge 21%, led by multibillion-dollar projects
[6] NAR: Existing-Home Sales
[7] NAHB: Amid Market Challenges, Builder Expectations Rise in October
[8] MarketWatch: Bayer’s stock is jumping on secondary stroke drug’s trial success
[9] SeekingAlpha: Prosus reports 1H results; on track to achieve FY adjusted EBITDA guidance
[10] Analytics India Magazine: US Court Upholds $194 Million Penalty Against TCS

---

Last Updated: Nov24,2025 at 7:00 AM EST | Data verified via primary sources | Compliance: Adhered to Ginlix’s traceability standards
Contact: analytics@ginlix.com | Version: MO-2025-1124-PM

©2025 Ginlix Analytics. All Rights Reserved.
Disclaimer: This report is for informational purposes only. Not investment advice.